BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15879939)

  • 1. Mounting a defense against Burkholderia cepacia.
    Godshall M
    Nursing; 2005 May; 35(5):18-9. PubMed ID: 15879939
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of pulsed-field gel electrophoresis in infection control issues concerning Burkholderia cepacia.
    Jenney A; Liolios L; Spelman D; Russo P; Wilson J; Wesselingh S; Kotsimbos T
    Infect Control Hosp Epidemiol; 2003 Aug; 24(8):624-6. PubMed ID: 12940588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The environmental risk factors associated with medical and dental equipment in the transmission of Burkholderia (Pseudomonas) cepacia in cystic fibrosis patients.
    Pankhurst CL; Philpott-Howard J
    J Hosp Infect; 1996 Apr; 32(4):249-55. PubMed ID: 8744509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.
    Govan JR
    J R Soc Med; 2000; 93 Suppl 38(Suppl 38):40-5. PubMed ID: 10911818
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudo outbreak of Burkholderia cepacia in vaginal cultures and intervention by hospital infection control team.
    Serikawa T; Kobayashi S; Tamura T; Uchiyama M; Tsukada H; Takakuwa K; Tanaka K; Ito M
    J Hosp Infect; 2010 Jul; 75(3):242-3. PubMed ID: 20434797
    [No Abstract]   [Full Text] [Related]  

  • 6. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].
    Segonds C; Chabanon G
    Ann Biol Clin (Paris); 2001; 59(3):259-69. PubMed ID: 11397673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segregation is good for patients with cystic fibrosis.
    Conway S
    J R Soc Med; 2008 Jul; 101 Suppl 1(Suppl 1):S31-5. PubMed ID: 18607016
    [No Abstract]   [Full Text] [Related]  

  • 8. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages.
    Agodi A; Barchitta M; Gianninò V; Collura A; Pensabene T; Garlaschi ML; Pasquarella C; Luzzaro F; Sinatra F; Mahenthiralingam E; Stefani S
    J Hosp Infect; 2002 Mar; 50(3):188-95. PubMed ID: 11886194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cystic fibrosis and Burkholderia (formerly Pseudomonas) cepacia: an increasing clinical and psychosocial problem].
    Horrevorts AM; Heijerman HG; Möller AV; Dankert-Roelse JE; Mouton JW; van der Laag J; Dankert J
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2343-6. PubMed ID: 7501071
    [No Abstract]   [Full Text] [Related]  

  • 10. [Burkholderia cepacia: a new pathogen causing nosocomial infections].
    Lipowski D; Rzadkiewicz E; Czekalska-Lachowicz E
    Przegl Epidemiol; 2008; 62(1):7-17. PubMed ID: 18536220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia cepacia: another twist and a further threat.
    Webb AK; Govan JR
    Thorax; 1998 May; 53(5):333-4. PubMed ID: 9708220
    [No Abstract]   [Full Text] [Related]  

  • 12. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism.
    Moore JE; Millar BC; Xu J; Crowe M; Redmond AO; Elborn JS
    J Clin Pathol; 2002 Apr; 55(4):309-11. PubMed ID: 11919219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the killer in cystic fibrosis.
    Hearst JE; Elliott KE
    Nat Med; 1995 Jul; 1(7):626-7. PubMed ID: 7585137
    [No Abstract]   [Full Text] [Related]  

  • 14. Burkholderia cepacia: medical, taxonomic and ecological issues.
    Govan JR; Hughes JE; Vandamme P
    J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of Burkholderia cepacia bloodstream infections traced to the use of Ringer lactate solution as multiple-dose vial for catheter flushing, Phnom Penh, Cambodia.
    De Smet B; Veng C; Kruy L; Kham C; van Griensven J; Peeters C; Ieng S; Phe T; Vlieghe E; Vandamme P; Jacobs J
    Clin Microbiol Infect; 2013 Sep; 19(9):832-7. PubMed ID: 23173820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist.
    Ramsey AH; Skonieczny P; Coolidge DT; Kurzynski TA; Proctor ME; Davis JP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):423-6. PubMed ID: 11583210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing Burkholderia cepacia complex infection in cystic fibrosis: is there a middle ground?
    Lipuma JJ
    J Pediatr; 2002 Oct; 141(4):467-9. PubMed ID: 12378182
    [No Abstract]   [Full Text] [Related]  

  • 18. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital.
    Siddiqui AH; Mulligan ME; Mahenthiralingam E; Hebden J; Brewrink J; Qaiyumi S; Johnson JA; LiPuma JJ
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):419-22. PubMed ID: 11583209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy?
    Ensor E; Humphreys H; Peckham D; Webster C; Knox AJ
    J Hosp Infect; 1996 Jan; 32(1):9-15. PubMed ID: 8904368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkholderia cepacia in cystic fibrosis: implications for nursing practice.
    Henskens JE; VonNessen SK
    Pediatr Nurs; 2000; 26(3):325-8. PubMed ID: 12026400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.